Demonstrates accelerated wound healing in infected wounds using a multifunctional hydrogel dressing, suggesting effective tissue repair strategies.
Endogenous signaling molecules are essential for coordinated wound healing, yet current donor-based dressings typically provide only single-mediator delivery with limited release duration. Here, a multifunctional hydrogel dressing, HEVCTM, is developed by free radical copolymerization of N -hydroxyethyl acrylamide (HEAA) with a hydrogen peroxide (H 2 O 2 ) releasing donor (VIM-CAT) and a hydrogen sulfide (H 2 S) releasing donor (TBA-MA). The hydrogel enables temporally programmed release, with rapid H 2 O 2 delivery within 24 h for early stage antibacterial action and sustained H 2 S release for up to 7 days to alleviate inflammation and promote angiogenesis during later healing stages. HEVCTM exhibits potent antibacterial activity against Escherichia coli (99.6%) and Staphylococcus aureus (99.97%), significantly enhances macrophage M2 polarization (52.4%), and shows favorable antioxidant, hemostatic, adhesive, and pro-angiogenic properties. Moreover, in an infected mouse wound model, HEVCTM significantly accelerated wound healing and promoted tissue regeneration. This work provides a bioactive hydrogel platform that matches the dynamic requirements of wound healing and effectively accelerates tissue repair.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: